Bringing the fundamentals into focus…
Back to Atara Biotherapeutics, Inc.
How Atara Biotherapeutics, Inc. stacks up
ATRA · against 76 other Healthcare companies of similar size
Valuation
8/ 100
Near the bottom of its peers.
Ranked #56 of 77 · scores higher than 9% of peers
Bars: peers in each 10-point band of the valuation score22 peers with a valuation score of 0–9, including ATRA · Click a bar to see the companies
Why valuation scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its free cash flow yield, EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -26.6% vs peer median 0.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. EBITDA yield: -13.4% vs peer median 4.0%
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -15.9% vs peer median 1.5%
Metric by metric
Position: dot = ATRA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ATRA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 61 reported | -15.9% | -11.9% | 45% | 30% | |
| EBITDA yieldHigher is better · 86 reported | -13.4% | -1.0% | 35% | 50% | |
| Free cash flow yieldHigher is better · 58 reported | -26.6% | -12.9% | 33% | 20% | |
| Book yieldHigher is better · 66 reported | -47.8% | 69.7% | 6% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around ATRA| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 1.1B HKD (≈$146M) | 99 | 72 | |
| 1 | 834M HKD (≈$107M) | 99 | 57 | |
| 1 | 592M ILS (≈$160M) | 99 | 84 | |
| 1 | 212M AUD (≈$140M) | 99 | 61 | |
| 5 | 4.5B TWD (≈$138M) | 98 | 62 | |
| 47 | 84M CAD (≈$61M) | 30 | 24 | |
| 47 | 63M EUR (≈$70M) | 30 | 46 | |
| 56 | 3.4B TWD (≈$106M) | 8 | 36 | |
| 56 | 115M USD | 8 | 8 | |
| 56 | 82M USD | 8 | 27 | |
| 56 | 118M USD | 8 | 13 | |
| 56 | 67M USD | 8 | ||
| 56 | 90M USD | 8 | 27 | |
| 56 | 94M USD | 8 | 8 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score